Zoran Zdraveski

Zoran Zdraveski files SEC Form 4 disclosures for TScan Therapeutics, Inc.. They have made 3 open-market trades across 2 companies since 2019, most recently 2024-08-23.

CIK 0001741285

Get an email the next time Zoran Zdraveski files.Follow for free

1 open-market purchase totalling $35K since 2021, against 2 sales. Too few scored purchases to measure a record yet.

Current Position

Ticker	Shares	Value
MGTA	140,092	$1.6M
TCRX	4,716	$1K
Total		$1.6M

Shares reported on the most recent Form 4, priced at the 2024-08-27 close.

Grade by Ticker

CTCRX

awaiting returns

Get an email the next time Zoran Zdraveski files

Free account. One email when the next filing comes in.

Follow Zoran Zdraveski for free

Buy Track Record

Filings1

Only 1 discretionary filing — too few to score

Discretionary filings only. 10b5-1 plan trades, tax withholding and option exercises are excluded, and each column is one row per filing rather than per execution lot.

Sell Track Record

Filings2

Only 1 decision-sell filing — too few to score

Decision sells only — a first sale after buying the stock, or a sale by a fund or 10% owner. Ordinary sales by officers and directors show no relationship to what the stock does next, so they are counted but not scored.

Routine0%

10b5-1 Plan50%

Volume by Type

SOpen-Market Sale

$2.2M

2 filings

MOption Exercise

$578K

2 filings

Companies

Trade History

3 total

TCRXSELL

$1.9M

2024-08-237d: +3.5%

Opportunistic SellExercise & Sell

•Decreased holdings by 97%
•Stock down -33% in previous 3 months
+1 more

TCRXBUY

$35K

2021-09-237d: -5.9%

First-Time BuyerBuying the DipTop TradeOpportunistic Buy

MGTASELL

$260K

2019-12-237d: +0.1%

Top TradeExercise & SellOpportunistic Sell

•Decreased holdings by 6%
•4 other insiders also sold in last 30 days
+1 more

Ticker	Type	Traded	Filed	Price	Value	7d Stock	30d Stock	90d Stock
TCRX	SELL	2024-08-23	2024-08-27	$5.78	$1.9M	+3.5%	-12.3%	-20.3%
TCRX	BUY	2021-09-23	2021-09-27	$7.48	$35K	-5.9%	-2.7%	-42.4%
MGTA	SELL	2019-12-23	2019-12-30	$16.02	$260K	+0.1%	-13.9%	-53.2%

Related Insiders

Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.